Monday, June 19, 2023 9:50:07 AM
Wow everyone interested in BDPT should read this post multiple times. Don’t want to spread price targets out there but sure looks like it doesn’t belong trading in low dubs. Too much happening, and true, after 10 years in business no RS and OS is still very low, I don’t expect a sudden sharp increase in extra shares being distributed.
It’s been a long time coming voor BioAdaptives, with the most recent high profile recruitments, looks like it’s ready for the next stage of growth.
There is nothing quite like a Biotech on the rise on the OTC. Nothing compares in regards to risk/reward ratio.
So happy to be here!!!
It’s been a long time coming voor BioAdaptives, with the most recent high profile recruitments, looks like it’s ready for the next stage of growth.
There is nothing quite like a Biotech on the rise on the OTC. Nothing compares in regards to risk/reward ratio.
So happy to be here!!!
Recent BDPT News
- BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night • GlobeNewswire Inc. • 04/28/2026 02:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/14/2026 08:05:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 02:45:46 AM
- BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing • GlobeNewswire Inc. • 10/07/2025 03:48:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 07:16:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 08:05:36 PM
